Search
Close this search box.
Search
Close this search box.

February 1, 2024

Within3’s Jason Smith in Journal of mHealth

Patient insights are valuable and should be prioritized as a critical piece of any insight-gathering strategy.
value of patient insights

In the Journal of mHealth, Within3 Chief Technology Officer Jason Smith writes about the value of patient insights and how pharma teams can harness them to their full potential.

“The quest for these ‘a-ha’ moments extends beyond data accumulation; it involves delving into the intricate tapestry of patient experiences, clinical trials, and drug reactions,” writes Smith. “The power of these insights lies in their rarity and transformative capability to shape strategies and cater directly to customer needs.”

When repurposed effectively, patient insights pave the way for a future that is more attuned to the needs of those it serves. This reorientation fosters an environment where patients are not just recipients of care but active participants in their own health journey, improving care for others as well. Insights facilitate the creation of tailored solutions and treatments, steering healthcare toward a more empathetic and patient-centric future.

“It is imperative to understand that patient insights are not just data points but narratives that transcend the confines of clinical trials and drug reactions,” says Smith. “Insights guide the healthcare industry toward a more compassionate and effective approach.”

Read the full article in Journal of mHealth.

Related Posts:

Within3 Raises over $100 Million in Growth Funding to Fuel Rapid Global Expansion

insights innovation for medical affairs

CEO Lance Hill in Gold Magazine

virtual engagement for medical affairs

Within3 in MedCityNews: Digital collaboration here to stay for Pfizer, Merck, others

More insights, direct to your inbox.